National brain tumour research funding needs to increase to £35 million a year
Husband’s Brainathlon Half raises nearly £2,000
Following his wife’s diagnosis with a brain tumour, a man has completed the Brainathlon Half to raise funds for three leading UK neuro research charities.
Sharon Jones was diagnosed with a meningioma in March 2021, four years after she first started suffering from symptoms. Sharon’s tumour is operable but due to COVID-19, surgery to remove it has been delayed and she is currently on a ‘watch and wait’.
With no immediate action to be taken to treat Sharon’s brain tumour, her husband David turned to fundraising. He took part in the Brainathlon Half, a walk, run and climb relay challenge raising funds to support three leading neuro research charities: Brain Tumour Research, Brain Research UK and Epilepsy Research UK.
David completed his challenge on 29th September, during his leave from his job at sea. Starting at the pier in Llandudno, he ran over Little Orme to Porth Eirias and then back to Rhos Point in Rhos-on-Sea. David fulfilled the climbing element of the challenge at Great Orme.
He said: “I set out with a fundraising target of £100 and I’m absolutely blown away to have raised nearly £1,900 for Brain Research UK, Brain Tumour Research and Epilepsy Research UK. I’ve had great support from family, friends and colleagues, who’ve given generously. I’m a Royal Navy veteran and have also received donations from people I served with in the past, which has been really gratifying.”
Brainathlon Half is a fun, family-friendly fundraiser which challenges participants to walk 5 miles, run 7.5 miles and climb 0.6 miles to complete the full 13.1 miles during Brainathlon Half week (Monday 25th to Sunday 31st October). Funds raised will be distributed equally to support research, improve outcomes and help people affected by neurological conditions, including epilepsy and brain tumours.
For more information and to register for the Brainathlon Half, please visit https://brainathlon.realbuzzevents.com/en/
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.